MedPath

康方赛诺医药有限公司

Ownership
-
Established
2019-04-30
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Ivonescimab Injection

Product Name
依达方
Approval Number
国药准字S20240020
Approval Date
May 21, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.